Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Mir-106B-5p Promotes Stem Cell-Like Properties of Hepatocellular Carcinoma Cells by Targeting PTEN Via PI3K/Akt Pathway

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

Mir-3682-3p Directly Targets FOXO3 and Stimulates Tumor Stemness in Hepatocellular Carcinoma Via a Positive Feedback Loop Involving FOXO3/PI3K/AKT/c-Myc

MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

Mir-217 Targeting DKK1 Promotes Cancer Stem Cell Properties Via Activation of the Wnt Signaling Pathway in Hepatocellular Carcinoma.

MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN

Mir-32 Induces Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting Pten

Mir-532-3p Promotes Hepatocellular Carcinoma Progression by Targeting PTPRT.

Pterostilbene Increases PTEN Expression Through the Targeted Downregulation of Microrna-19A in Hepatocellular Carcinoma

microRNA-106b-5p Promotes Cell Growth and Sensitizes Chemosensitivity to Sorafenib by Targeting the BTG3/Bcl-xL/p27 Signaling Pathway in Hepatocellular Carcinoma

Mir-206 Inhibits Cell Proliferation, Invasion, and Migration by Down-Regulating PTP1B in Hepatocellular Carcinoma.

Mir-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14.

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Mir-106A Promotes Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting PTEN.

Mir-296-5p Suppresses EMT of Hepatocellular Carcinoma Via Attenuating NRG1/ERBB2/ERBB3 Signaling

Mir-4319 Induced An Inhibition Of Epithelial-Mesenchymal Transition And Prevented Cancer Stemness Of Hcc Through Targeting Foxq1

MicroRNA-452 Promotes Stem-Like Cells of Hepatocellular Carcinoma by Inhibiting Sox7 Involving Wnt/β-catenin Signaling Pathway

Mir-218 Modulate Hepatocellular Carcinoma Cell Proliferation Through PTEN/AKT/PI3K Pathway and HoxA10.

Mir-221/222 Promote Cancer Stem-Like Cell Properties and Tumor Growth of Breast Cancer Via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation.